Literature DB >> 15704783

Natural history, evaluation, and management of intracranial vascular malformations.

Robert D Brown1, Kelly D Flemming, Fredric B Meyer, Harry J Cloft, Bruce E Pollock, Michael L Link.   

Abstract

Intracranial vascular malformations are seen increasingly in clinical practice, primarily because of advances in cross-sectional brain and spinal cord imaging. Commonly encountered lesion types include arteriovenous malformations, cavernous malformations, venous malformations, dural arteriovenous fistulas, and capillary telangiectasias. Patients can experience various symptoms and signs at presentation. The natural history of vascular malformations depends on lesion type, location, size, and overall hemodynamics. The natural history for each lesion subtype is reviewed, with special consideration of the risk of hemorrhage or other adverse outcomes after the lesion is detected and any known predictors of hemorrhage or other outcomes. In practice, these data are compared with the risk of available treatment options as the optimal management is clarified. A multidisciplinary approach including neurosurgery, radiosurgery, interventional neuroradiology, and vascular neurology is most useful in determining the best management strategy.

Entities:  

Mesh:

Year:  2005        PMID: 15704783     DOI: 10.4065/80.2.269

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  20 in total

Review 1.  Intracranial dural arteriovenous fistulas: classification, imaging findings, and treatment.

Authors:  D Gandhi; J Chen; M Pearl; J Huang; J J Gemmete; S Kathuria
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

2.  MRI using ferumoxytol improves the visualization of central nervous system vascular malformations.

Authors:  Edit Dósa; Suchita Tuladhar; Leslie L Muldoon; Bronwyn E Hamilton; William D Rooney; Edward A Neuwelt
Journal:  Stroke       Date:  2011-04-14       Impact factor: 7.914

Review 3.  Radiosurgery for intracranial dural arteriovenous fistulas (DAVFs): a review.

Authors:  Ioannis Loumiotis; Giuseppe Lanzino; David Daniels; Jason Sheehan; Michael Link
Journal:  Neurosurg Rev       Date:  2011-05-17       Impact factor: 3.042

Review 4.  Management of ruptured brain arteriovenous malformations.

Authors:  Brad E Zacharia; Kerry A Vaughan; Adam Jacoby; Zachary L Hickman; Daniel Bodmer; E Sander Connolly
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

5.  Balloon protection of the Labbé vein during transarterial embolization of a dural arterio-venous fistula.

Authors:  Raoul Pop; Monica Manisor; Valérie Wolff; Ziad Aloraini; Leonardo Tigan; Pierre Kehrli; Christian Marescaux; Rémy Beaujeux
Journal:  Interv Neuroradiol       Date:  2015-10-05       Impact factor: 1.610

6.  Radiosurgical treatment of arteriovenous malformations in a retrospective study group of 33 children: the importance of radiobiological scores.

Authors:  Jody Filippo Capitanio; Pietro Panni; Alberto Luigi Gallotti; Carmen Rosaria Gigliotti; Francesco Scomazzoni; Stefania Acerno; Antonella Del Vecchio; Pietro Mortini
Journal:  Childs Nerv Syst       Date:  2018-11-24       Impact factor: 1.475

Review 7.  Pediatric stroke.

Authors:  Javier F Cárdenas; Jong M Rho; Adam Kirton
Journal:  Childs Nerv Syst       Date:  2011-02-20       Impact factor: 1.475

Review 8.  Role of conventional magnetic resonance imaging in the screening of epilepsy with structural abnormalities: a pictorial essay.

Authors:  Xu Zhao; Zhiqiang Zhou; Wenzhen Zhu; Hongbing Xiang
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

Review 9.  Intracranial Dural Arteriovenous Fistulae.

Authors:  Matthew R Reynolds; Giuseppe Lanzino; Gregory J Zipfel
Journal:  Stroke       Date:  2017-05       Impact factor: 7.914

10.  Management of intracranial cavernous malformation in pediatric patients.

Authors:  Jae-Whan Lee; Dong-Seok Kim; Kyu-Won Shim; Jong-Hee Chang; Seung-Kon Huh; Yong-Gou Park; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.